Effect of vagotomy on ornithine decarboxylase activity in rat duodenal mucosa. 1993

J Tanaka, and K Fujimoto, and T Sakata, and T Fujimoto, and S Tsunada, and R Iwakiri, and M Yamaguchi, and Y Okabe, and H Yoshimatsu
Department of Internal Medicine, Saga Medical School, Japan.

The aim of this study was to determine whether the circadian rhythm of ornithine decarboxylase (ODC) activity in rat small intestine is controlled by factors other than luminal nutrients. ODC activity in duodenal and jejunal mucosa of rats fed ad libitum was measured at four time points (0500, 1100, 1700, 2300 h; light period: 0800-2000 h). ODC activity in the jejunum increased in the dark period, which is when rats normally eat. In contrast, ODC activity in the duodenum began to increase at 1700 h, which is when rats do not normally eat, as indicated by the recorded feeding pattern. The increase in ODC activity in the duodenum at 1700 h, but not at other time points, was abolished by subdiaphragmatic vagotomy, whereas vagotomy had no effect on the feeding pattern of rats. Subdiaphragmatic vagotomy had no effect on ODC activity in the jejunum. ODC activity in the duodenum increased following glycoprivation of the central nervous system induced by infusion of 2-deoxyglucose into the third cerebroventricle. These results indicate that the increase in duodenal ODC activity at 1700 h is due to a signal from the upper brain structure through the vagal nerve and not to luminal nutrient factors.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D007583 Jejunum The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum. Jejunums
D008297 Male Males
D009955 Ornithine Decarboxylase A pyridoxal-phosphate protein, believed to be the rate-limiting compound in the biosynthesis of polyamines. It catalyzes the decarboxylation of ornithine to form putrescine, which is then linked to a propylamine moiety of decarboxylated S-adenosylmethionine to form spermidine. Ornithine Carboxy-lyase,Carboxy-lyase, Ornithine,Decarboxylase, Ornithine,Ornithine Carboxy lyase
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002552 Cerebral Ventricles Four CSF-filled (see CEREBROSPINAL FLUID) cavities within the cerebral hemispheres (LATERAL VENTRICLES), in the midline (THIRD VENTRICLE) and within the PONS and MEDULLA OBLONGATA (FOURTH VENTRICLE). Foramen of Monro,Cerebral Ventricular System,Cerebral Ventricle,Cerebral Ventricular Systems,Monro Foramen,System, Cerebral Ventricular,Systems, Cerebral Ventricular,Ventricle, Cerebral,Ventricles, Cerebral,Ventricular System, Cerebral,Ventricular Systems, Cerebral
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D003847 Deoxyglucose 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity. 2-Deoxy-D-glucose,2-Deoxyglucose,2-Desoxy-D-glucose,2 Deoxy D glucose,2 Deoxyglucose,2 Desoxy D glucose
D004386 Duodenum The shortest and widest portion of the SMALL INTESTINE adjacent to the PYLORUS of the STOMACH. It is named for having the length equal to about the width of 12 fingers. Duodenums

Related Publications

J Tanaka, and K Fujimoto, and T Sakata, and T Fujimoto, and S Tsunada, and R Iwakiri, and M Yamaguchi, and Y Okabe, and H Yoshimatsu
March 1987, Biulleten' eksperimental'noi biologii i meditsiny,
J Tanaka, and K Fujimoto, and T Sakata, and T Fujimoto, and S Tsunada, and R Iwakiri, and M Yamaguchi, and Y Okabe, and H Yoshimatsu
January 1986, Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR,
J Tanaka, and K Fujimoto, and T Sakata, and T Fujimoto, and S Tsunada, and R Iwakiri, and M Yamaguchi, and Y Okabe, and H Yoshimatsu
January 1991, Canadian journal of physiology and pharmacology,
J Tanaka, and K Fujimoto, and T Sakata, and T Fujimoto, and S Tsunada, and R Iwakiri, and M Yamaguchi, and Y Okabe, and H Yoshimatsu
March 1990, Gan no rinsho. Japan journal of cancer clinics,
J Tanaka, and K Fujimoto, and T Sakata, and T Fujimoto, and S Tsunada, and R Iwakiri, and M Yamaguchi, and Y Okabe, and H Yoshimatsu
December 1992, Cell biochemistry and function,
J Tanaka, and K Fujimoto, and T Sakata, and T Fujimoto, and S Tsunada, and R Iwakiri, and M Yamaguchi, and Y Okabe, and H Yoshimatsu
September 1992, Canadian journal of physiology and pharmacology,
J Tanaka, and K Fujimoto, and T Sakata, and T Fujimoto, and S Tsunada, and R Iwakiri, and M Yamaguchi, and Y Okabe, and H Yoshimatsu
June 1977, Biochemical and biophysical research communications,
J Tanaka, and K Fujimoto, and T Sakata, and T Fujimoto, and S Tsunada, and R Iwakiri, and M Yamaguchi, and Y Okabe, and H Yoshimatsu
February 1978, Biochemical and biophysical research communications,
J Tanaka, and K Fujimoto, and T Sakata, and T Fujimoto, and S Tsunada, and R Iwakiri, and M Yamaguchi, and Y Okabe, and H Yoshimatsu
October 1981, European journal of pharmacology,
J Tanaka, and K Fujimoto, and T Sakata, and T Fujimoto, and S Tsunada, and R Iwakiri, and M Yamaguchi, and Y Okabe, and H Yoshimatsu
August 1986, Japanese journal of cancer research : Gann,
Copied contents to your clipboard!